img

Global Blood Cancer Molecular Diagnostics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Blood Cancer Molecular Diagnostics Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Blood Cancer Molecular Diagnostics Market
Global Blood Cancer Molecular Diagnostics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Blood Cancer Molecular Diagnostics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Blood Cancer Molecular Diagnostics key companies include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Agilent, Liferiver, Gpmedical and Zeesan, etc. Roche Diagnostics, Abbott, Thermo Fisher are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Blood Cancer Molecular Diagnostics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Blood Cancer Molecular Diagnostics market and estimated to attract more attentions from industry insiders and investors.
Blood Cancer Molecular Diagnostics can be divided into Polymerase Chain Reaction, Molecular Hybridization, Biochip and Others, etc. Polymerase Chain Reaction is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Blood Cancer Molecular Diagnostics is widely used in various fields, such as Hospital, Third-Party Testing Agency and Others,, etc. Hospital provides greatest supports to the Blood Cancer Molecular Diagnostics industry development. In 2022, global % revenue of Blood Cancer Molecular Diagnostics went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Blood Cancer Molecular Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Blood Cancer Molecular Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Agilent
Liferiver
Gpmedical
Zeesan
Berry Oncology
Annoroad
Segment by Type
Polymerase Chain Reaction
Molecular Hybridization
Biochip
Others

Segment by Application


Hospital
Third-Party Testing Agency
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Blood Cancer Molecular Diagnostics introduction, etc. Blood Cancer Molecular Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Blood Cancer Molecular Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Polymerase Chain Reaction
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Cancer Molecular Diagnostics Market Perspective (2018-2033)
2.2 Global Blood Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Blood Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Blood Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Blood Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Blood Cancer Molecular Diagnostics Market Dynamics
2.3.1 Blood Cancer Molecular Diagnostics Industry Trends
2.3.2 Blood Cancer Molecular Diagnostics Market Drivers
2.3.3 Blood Cancer Molecular Diagnostics Market Challenges
2.3.4 Blood Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Blood Cancer Molecular Diagnostics by Players
3.1.1 Global Blood Cancer Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Blood Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Blood Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Blood Cancer Molecular Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Blood Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Blood Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Cancer Molecular Diagnostics Revenue in 2022
3.5 Global Key Players of Blood Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Blood Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Blood Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Blood Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2033)
5 Blood Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Blood Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Blood Cancer Molecular Diagnostics Market Size (2018-2033)
6.2 North America Blood Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033)
6.2.3 North America Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
6.3 North America Blood Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033)
6.3.3 North America Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
6.4 North America Blood Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Blood Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Blood Cancer Molecular Diagnostics Market Size (2018-2033)
7.2 Europe Blood Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
7.3 Europe Blood Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
7.4 Europe Blood Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Blood Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Blood Cancer Molecular Diagnostics Market Size (2018-2033)
8.2 China Blood Cancer Molecular Diagnostics Market Size by Type
8.2.1 China Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033)
8.2.3 China Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
8.3 China Blood Cancer Molecular Diagnostics Market Size by Application
8.3.1 China Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033)
8.3.3 China Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Blood Cancer Molecular Diagnostics Market Size (2018-2033)
9.2 Asia Blood Cancer Molecular Diagnostics Market Size by Type
9.2.1 Asia Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
9.3 Asia Blood Cancer Molecular Diagnostics Market Size by Application
9.3.1 Asia Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
9.4 Asia Blood Cancer Molecular Diagnostics Market Size by Region
9.4.1 Asia Blood Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Blood Cancer Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Blood Cancer Molecular Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Blood Cancer Molecular Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.1.5 Roche Diagnostics Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Blood Cancer Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Blood Cancer Molecular Diagnostics Introduction
11.3.4 Thermo Fisher Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.3.5 Thermo Fisher Recent Developments
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Blood Cancer Molecular Diagnostics Introduction
11.4.4 Qiagen Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.4.5 Qiagen Recent Developments
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Blood Cancer Molecular Diagnostics Introduction
11.5.4 Illumina Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.5.5 Illumina Recent Developments
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Blood Cancer Molecular Diagnostics Introduction
11.6.4 Agilent Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.6.5 Agilent Recent Developments
11.7 Liferiver
11.7.1 Liferiver Company Details
11.7.2 Liferiver Business Overview
11.7.3 Liferiver Blood Cancer Molecular Diagnostics Introduction
11.7.4 Liferiver Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.7.5 Liferiver Recent Developments
11.8 Gpmedical
11.8.1 Gpmedical Company Details
11.8.2 Gpmedical Business Overview
11.8.3 Gpmedical Blood Cancer Molecular Diagnostics Introduction
11.8.4 Gpmedical Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.8.5 Gpmedical Recent Developments
11.9 Zeesan
11.9.1 Zeesan Company Details
11.9.2 Zeesan Business Overview
11.9.3 Zeesan Blood Cancer Molecular Diagnostics Introduction
11.9.4 Zeesan Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.9.5 Zeesan Recent Developments
11.10 Berry Oncology
11.10.1 Berry Oncology Company Details
11.10.2 Berry Oncology Business Overview
11.10.3 Berry Oncology Blood Cancer Molecular Diagnostics Introduction
11.10.4 Berry Oncology Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.10.5 Berry Oncology Recent Developments
11.11 Annoroad
11.11.1 Annoroad Company Details
11.11.2 Annoroad Business Overview
11.11.3 Annoroad Blood Cancer Molecular Diagnostics Introduction
11.11.4 Annoroad Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023)
11.11.5 Annoroad Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Molecular Hybridization
Table 4. Key Players of Biochip
Table 5. Key Players of Others
Table 6. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Blood Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Blood Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Blood Cancer Molecular Diagnostics Market Share by Region (2024-2033)
Table 12. Blood Cancer Molecular Diagnostics Market Trends
Table 13. Blood Cancer Molecular Diagnostics Market Drivers
Table 14. Blood Cancer Molecular Diagnostics Market Challenges
Table 15. Blood Cancer Molecular Diagnostics Market Restraints
Table 16. Global Blood Cancer Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Blood Cancer Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Blood Cancer Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Molecular Diagnostics as of 2022)
Table 19. Global Blood Cancer Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Blood Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Blood Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Blood Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Blood Cancer Molecular Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Blood Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2033)
Table 29. Global Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Blood Cancer Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Blood Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Blood Cancer Molecular Diagnostics Revenue Share by Application (2024-2033)
Table 33. North America Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Blood Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Blood Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Blood Cancer Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Blood Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Blood Cancer Molecular Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 65. Roche Diagnostics Company Details
Table 66. Roche Diagnostics Business Overview
Table 67. Roche Diagnostics Blood Cancer Molecular Diagnostics Product
Table 68. Roche Diagnostics Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Roche Diagnostics Recent Developments
Table 70. Abbott Company Details
Table 71. Abbott Business Overview
Table 72. Abbott Blood Cancer Molecular Diagnostics Product
Table 73. Abbott Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Abbott Recent Developments
Table 75. Thermo Fisher Company Details
Table 76. Thermo Fisher Business Overview
Table 77. Thermo Fisher Blood Cancer Molecular Diagnostics Product
Table 78. Thermo Fisher Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Thermo Fisher Recent Developments
Table 80. Qiagen Company Details
Table 81. Qiagen Business Overview
Table 82. Qiagen Blood Cancer Molecular Diagnostics Product
Table 83. Qiagen Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Qiagen Recent Developments
Table 85. Illumina Company Details
Table 86. Illumina Business Overview
Table 87. Illumina Blood Cancer Molecular Diagnostics Product
Table 88. Illumina Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Illumina Recent Developments
Table 90. Agilent Company Details
Table 91. Agilent Business Overview
Table 92. Agilent Blood Cancer Molecular Diagnostics Product
Table 93. Agilent Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Agilent Recent Developments
Table 95. Liferiver Company Details
Table 96. Liferiver Business Overview
Table 97. Liferiver Blood Cancer Molecular Diagnostics Product
Table 98. Liferiver Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Liferiver Recent Developments
Table 100. Gpmedical Company Details
Table 101. Gpmedical Business Overview
Table 102. Gpmedical Blood Cancer Molecular Diagnostics Product
Table 103. Gpmedical Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Gpmedical Recent Developments
Table 105. Zeesan Company Details
Table 106. Zeesan Business Overview
Table 107. Zeesan Blood Cancer Molecular Diagnostics Product
Table 108. Zeesan Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 109. Zeesan Recent Developments
Table 110. Berry Oncology Company Details
Table 111. Berry Oncology Business Overview
Table 112. Berry Oncology Blood Cancer Molecular Diagnostics Product
Table 113. Berry Oncology Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Berry Oncology Recent Developments
Table 115. Annoroad Company Details
Table 116. Annoroad Business Overview
Table 117. Annoroad Blood Cancer Molecular Diagnostics Product
Table 118. Annoroad Revenue in Blood Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Annoroad Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Blood Cancer Molecular Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Polymerase Chain Reaction Features
Figure 4. Molecular Hybridization Features
Figure 5. Biochip Features
Figure 6. Others Features
Figure 7. Global Blood Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Blood Cancer Molecular Diagnostics Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Third-Party Testing Agency Case Studies
Figure 11. Others Case Studies
Figure 12. Blood Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Blood Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Blood Cancer Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Blood Cancer Molecular Diagnostics Market Share by Region: 2022 VS 2033
Figure 16. Global Blood Cancer Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Blood Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Blood Cancer Molecular Diagnostics Revenue in 2022
Figure 19. North America Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
Figure 21. North America Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
Figure 22. North America Blood Cancer Molecular Diagnostics Market Share by Country (2018-2033)
Figure 23. United States Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Blood Cancer Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
Figure 27. Europe Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
Figure 28. Europe Blood Cancer Molecular Diagnostics Market Share by Country (2018-2033)
Figure 29. Germany Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Blood Cancer Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
Figure 37. China Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
Figure 38. Asia Blood Cancer Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
Figure 40. Asia Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
Figure 41. Asia Blood Cancer Molecular Diagnostics Market Share by Region (2018-2033)
Figure 42. Japan Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Blood Cancer Molecular Diagnostics Market Share by Country (2018-2033)
Figure 52. Brazil Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Blood Cancer Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Roche Diagnostics Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 59. Abbott Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 60. Thermo Fisher Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 61. Qiagen Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 62. Illumina Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 63. Agilent Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 64. Liferiver Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 65. Gpmedical Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 66. Zeesan Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 67. Berry Oncology Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 68. Annoroad Revenue Growth Rate in Blood Cancer Molecular Diagnostics Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries